Verix, the leading provider of Tovana, an AI driven commercial optimization platform for the pharmaceutical industry, announced that it has acquired start-up.ai, a team of AI specialists that helps businesses improve their processes using artificial intelligence and machine learning. The start-up.ai team will be fully integrated into Verix's AI lab, with Shahar Cohen, start-up.ai's co-founder and CEO, to serve as Verix's CTO.

Pharmaceutical companies currently often rely on consulting analytical services to make valuable marketing and sales decisions pertaining to their strategy and execution, which are time consuming and expensive. Verix uses AI, to assist in providing more in-depth, accurate information on the market at a fraction of the time and cost.

"Verix has been a long-time partner of start-up.ai and we have enjoyed working closely with the company as it has expanded its global footprint and its roster of tier-one pharma manufacturers and life sciences firms," said Shahar Cohen, co-founder and CEO of start-up.ai. "Verix's platform is the perfect place for implementing the technology we have spent years developing, allowing us to optimize the way we acquire, process, and utilize large data for the benefit of pharma companies, physicians and patients."

"In our time working with start-up.ai, we were consistently impressed with their AI capabilities and innovative approach to solving customer challenges," said Doron Aspitz, CEO of Verix. "As we continue to grow, serving more and more customers, we understand the strategic value of continuing to build out category-leading AI capabilities, which are embedded in our opportunity engine platform "Tovana". Adding the start-up.ai team to Verix was a natural decision for us and we are excited for what our new capabilities will enable us to deliver to our customers and partners around the world."